company background image
GMED logo

Globus Medical NYSE:GMED Stock Report

Last Price

US$66.68

Market Cap

US$8.9b

7D

0.7%

1Y

13.7%

Updated

17 Jun, 2024

Data

Company Financials +

GMED Stock Overview

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

GMED fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance1/6
Financial Health5/6
Dividends0/6

Globus Medical, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Globus Medical
Historical stock prices
Current Share PriceUS$66.68
52 Week HighUS$67.89
52 Week LowUS$43.39
Beta1.15
1 Month Change3.54%
3 Month Change28.28%
1 Year Change13.73%
3 Year Change-9.22%
5 Year Change56.67%
Change since IPO393.93%

Recent News & Updates

Recent updates

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Apr 08
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Mar 20
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock

Feb 27

Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Feb 09
Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Jan 17
Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Globus Medical: Merger Overhang Lingering

Nov 27

Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Nov 14
Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Oct 27
Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Globus Medical: Almost Having My Back

Sep 13

Globus Medical: Slightly Too Pricey Right Now

Aug 07

Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy

Jul 18

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jul 11
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Jun 18
Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Apr 09
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Mar 22
What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Feb 24
Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Globus Medical Q4 2022 Earnings Preview

Feb 20

Globus Medical: An Impressive Long-Term Revenue Growth Play

Jan 08

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Dec 22
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Dec 01
Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line

Nov 08

A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Oct 15
A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact

Sep 02

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Sep 02
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Aug 11
Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective

Jun 05

Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

May 24
Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

May 06
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Mar 14
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Globus Medical Continues To Flex Its Innovation Muscles To Drive Share Growth

Mar 01

Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Feb 24
Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Feb 08
Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jan 21
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Shareholder Returns

GMEDUS Medical EquipmentUS Market
7D0.7%-1.4%1.6%
1Y13.7%-1.3%21.5%

Return vs Industry: GMED exceeded the US Medical Equipment industry which returned -0.9% over the past year.

Return vs Market: GMED underperformed the US Market which returned 20.8% over the past year.

Price Volatility

Is GMED's price volatile compared to industry and market?
GMED volatility
GMED Average Weekly Movement6.5%
Medical Equipment Industry Average Movement7.7%
Market Average Movement5.7%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.9%

Stable Share Price: GMED's share price has been volatile over the past 3 months.

Volatility Over Time: GMED's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20035,000Dan Scavillawww.globusmedical.com

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.

Globus Medical, Inc. Fundamentals Summary

How do Globus Medical's earnings and revenue compare to its market cap?
GMED fundamental statistics
Market capUS$8.86b
Earnings (TTM)US$66.63m
Revenue (TTM)US$1.90b

135.2x

P/E Ratio

4.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GMED income statement (TTM)
RevenueUS$1.90b
Cost of RevenueUS$593.51m
Gross ProfitUS$1.30b
Other ExpensesUS$1.24b
EarningsUS$66.63m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.49
Gross Margin68.74%
Net Profit Margin3.51%
Debt/Equity Ratio10.8%

How did GMED perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.